cancer and semaglutide GLP-1 drugs cancer: the headline is exciting. The full picture is more nuanced. New research from @ascocancer 2026 shows patients on GLP-1 medications like were up to 50% less likely has semaglutide cause cancer in

This trajectory was marked by features of epithelial-to-mesenchymal transition (EMT), providing a mechanistic explanation for both the shedding of degenerative aTECs into the urine and their contribution to fibroblast accumulation in DKD ( 4.3 Integrated multi-omics insights into DKD regulation Beyond transcriptomic analysis, the integration of single-cell RNA sequencing with assay for transposase-accessible chromatin (scATAC-seq) has enabled deeper insight into how gene regulatory networks are remodeled under diabetic conditions (Figure 3)

February is National Grapefruit Month

The manufacturers of GLP-1 medications have significant resources and will vigorously defend themselves against these legal claims

Thats a $600 gap, before any lab or coaching add-ons

(5) R C Rosen, L E Diamond, D C Earle, et al (2004) Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra International Journal of Impotence Research, volume 16, pages 135142 (2004)